PINTA - Prophylactic Incisional Negative Pressure Therapy for Major Amputations
NCT ID: NCT06025253
Last Updated: 2024-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
728 participants
INTERVENTIONAL
2024-03-01
2026-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds
NCT05977816
SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections
NCT03816293
Use of Negative Pressure Wound Therapy in High Risk Surgical Closed Incisions
NCT02137447
Prophylactic Negative Wound Therapy in Laparotomy Wounds.
NCT03871023
Negative Pressure Wound Therapy Use to Decrease Surgical Nosocomial Events in Colorectal Resections
NCT02007018
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One option amenable to alteration is what dressing is applied to the closed incision upon procedure completion. The type of dressing may influence factors such as bacterial access to the wound, the development of collections of blood or fluid in the wound or fluid oozing from the wound. Collectively, these wound factors increase the risk of wound infection. Therefore, dressings which reduce these factors have the potential to reduce wound breakdown, thereby reducing the burden for patients and healthcare systems.
The investigators propose to conduct a multicentre randomised controlled trial comparing prophylactic single-use negative pressure wound therapy with standard dressings in patients with a closed incision following major lower extremity amputation in terms of SSI incidence, wound healing complications and scar appearance, patient quality of life and financial impact on the patient and healthcare system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Negative Pressure Wound Therapy.
Application of a negative wound pressure therapy dressing to the wound post major lower extremity amputation
Negative Pressure Wound Therapy
Application of negative-pressure wound therapy (NPWT) post major lower extremity amputation
Standard Wound dressing
Application of sterile standard gauze dressing to the wound post major lower extremity amputation
Standard Wound Dressing
Application of standard wound dressing post major lower extremity amputation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Negative Pressure Wound Therapy
Application of negative-pressure wound therapy (NPWT) post major lower extremity amputation
Standard Wound Dressing
Application of standard wound dressing post major lower extremity amputation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing major lower extremity amputation, including below-knee amputation, through-knee amputation and above-knee amputation, for any indication;
* Patients with primary closure of the surgical incision using either interrupted or continuous sutures
Exclusion Criteria
* Women who are pregnant and/or breast-feeding;
* Patients with amputations performed without primary skin closure, including guillotine amputations, amputations deliberately left open for drainage purposes and amputations with soft tissues defects at the stump;
* Patients with amputations where skin glue is the only means of skin closure
* Patients with a clinically absent femoral pulse
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal College of Surgeons, Ireland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stewart Walsh, Prof
Role: PRINCIPAL_INVESTIGATOR
University Hospital Galway (UHG)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beaumont Hospital, Beaumont rd,Dublin 9, D09V2N0
Dublin, , Ireland
St Jamess Hospital
Dublin, , Ireland
St Vincents University Hospital
Dublin, , Ireland
Tallaght University Hospital
Dublin, , Ireland
University Hospital Galway
Galway, , Ireland
University Hospital Limerick
Limerick, , Ireland
University Hospital Waterford
Waterford, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Daragh Moneley
Role: primary
Zenia Martin
Role: primary
Hillary Hurley
Role: primary
Emily Boyle
Role: primary
Stewart Walsh
Role: primary
Zeeshan Ahmed
Role: primary
Gergely Gosi
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RCSI- PINTA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.